Medical devices and pharmaceuticals continue to gain momentum, entering new markets around the world and providing technological advances in disease management in a variety of conditions. However, such interventions can also carry predictable and unpredictable risks and, under certain circumstances, can have immediate, life-threatening consequences. Regulators assessing market approval for new products should weigh the […]
Author Archives: Mayur Kumar
Multichannel measurement – It’s Not All About ROI
Multichannel measurement in the pandemic predicted that marketers would spend 14.4% more on search advertising in 2020. However, in the early days of the pandemic, online search declined, and marketers weren’t getting the return on investment they expected from paid search advertising. However, despite the ongoing pandemic, marketers still expect search advertising spending to increase […]
Roi via online marketing – Can it be generated through OTC
During the COVID 19 pandemic, pharmaceutical brands had to keep their sales force fixed. As a result, marketers in organizations that focused primarily on face-to-face communication to reach doctors were soon forced to switch to a digital approach. During this time, pharmaceutical marketers have experienced higher ROI in their marketing initiatives by running campaigns on […]
Marketing in OTC – Differs from FMCG
Marketing in OTC was worth Rs 14,000 and accounted for almost 20% of the total pharmaceutical market in 2018. It is expected to grow rapidly over the next few years (10-15% per year). Multinationals are already well established, but domestic pharmaceutical companies are starting to grow aggressively. FMCG players are also doing their best to […]
Rare disease communities – Can teach pharma a lesson?
Rare disease communities have flowed from pharmaceutical companies to doctors to patients. Through the internet and social media, patients have access to not only medical journals, but also other patients and caregivers dealing with the same illness. The average person does not have the medical expertise or scientific training to interpret some of the information, […]
Gamification for learning – Drug Discovery and Development process
Gamification for learning works because our reaction to games is deeply embedded in our psychology. Kevin Werbach, an associate professor of law and business ethics at the University of Pennsylvania’s Wharton School, wrote in the conversation. Game design techniques recognize our innate desire to recognize patterns, solve puzzles, overcome challenges, collaborate with others, and experience […]
Using gamification for engagement – How Pharma industry can use it
If you have a smartphone, you may have already encountered gamification. An app that earns points and badges when you reach a new level or complete a task (usually a wellness challenge) is a form of gamification. Gamification uses extrinsic and intrinsic rewards to motivate users to change their behavior. It may help preventive medicine […]
Games for pharma marketing – How pharma marketers use it
Games for pharma marketing are starting to get attention by the medical industry as the influx of GenXers and Years into today’s workforce is pushing the industry`s conservative management leaders to play more games. Cuttingedge, fast paced, highly competitive computer based simulations and games designed to educate as they engage are gaining traction in the […]
Engagement with caregivers – How can pharma do it
Engagement with caregivers makes all financial and practical decisions for the patient. It’s time for a pharmaceutical company marketer to understand the caregiver’s mindset. Career Demography Caregivers are important, but often invisible forces behind US health care. In fact, each year, their total unpaid work exceeds the cost of all Medicaids. According to a 2015 […]
Pharmacy of the world’ – India’s potential to be
Pharmacy of the world’, the Indian pharmaceutical industry has the opportunity to play a greater role in the safety of global drug supply. Financial and political incentives can help achieve this. In 1969, Indian pharmaceuticals had a 5% market share in India and global pharmaceutical companies had a 95% share. By 2020, the opposite was […]